Indian drug maker Cipla has lost a challenge to the extension of Novo Nordisk’s patent for Victoza, with a judge rejecting an argument that extensions can be granted only for active ingredients.
A class action on behalf of 700 patients alleging Monash IVF destroyed potentially viable embryos has told a court the majority of late registrants should not share in the $56 million settlement.
The builders involved in Adelaide’s $1.85 billion Royal Adelaide Hospital have lost their appeal of a decision blocking their bid to access documents from the state government on parliamentary privilege grounds.
The High Court has settled a 16-year battle between the federal government and Sanofi over alleged excess subsidies it paid after a judge blocked the release of a generic version of blood thinner Plavix, saying its job was not to “resurrect” a dead case.
Medical device maker Bayer has successfully defended a class action over its Essure contraceptive, with a judge finding the evidence fell short of proving the device caused chronic inflammation.
The ACCC has given medical imaging company Integral Diagnostics the green light to acquire Capitol Health, after it offered to sell off one of 61 radiology clinics to win approval. On Tuesday, the competition regulator announced that it would not oppose the acquisition, which would see ASX-listed Integral Diagnostics acquire Capitol’s 60 radiology sites right…
US drug company Allergan is facing a class action on behalf of women implanted with textured breast implants that were recalled after they were linked to a form of non-Hodgkin lymphoma.
Bayer has filed a High Court challenge to a decision that invalidated its patents for blockbuster blood thinner Xarelto, saying it would adversely affect drug research and development.
As it fends off a suit by AstraZeneca seeking to block the sale of a cheaper version of Brilinta, generics maker Pharmacor claims a patent for the heart attack drug should not have been extended.
AI tech company Paige can’t patent a tool to provide quality control for analysis of pathology images, with IP Australia finding the invention is merely an “administrative scheme” to automate the role of human pathologists.